Estrella Immunopharma Completes Second Dose Cohort in STARLIGHT-1 Trial of EB103 with Complete Responses in All Evaluable Patients

.comp-l4zr92q41 { --wix-color-1: 255,255,255; --wix-color-2: 191,191,191; --wix-color-3: 128,128,128; --wix-color-4: 64,64,64; --wix-color-5: 0,0,0; --wix-color-6: 160,240,249; --wix-color-7: 65,224,243; --wix-color-8: 12,176,196; --wix-color-9: 8,117,131; --wix-color-10: 4,59,65; --wix-color-11: 208,208,208; --wix-color-12: 162,162,162; --wix-color-13: 115,115,115; --wix-color-14: 69,69,69; --wix-color-15: 22,22,22; --wix-color-16: 243,243,243; --wix-color-17: 230,230,230; --wix-color-18: 173,173,173; --wix-color-19: 115,115,115; --wix-color-20: 58,58,58; --wix-color-21: 137,235,248; --wix-color-22: 19,216,240; --wix-color-23: 12,164,183; --wix-color-24: 8,109,122; --wix-color-25: 4,55,61; --wix-color-26: 255,255,255; --wix-color-27: 0,0,0; --wix-color-28: 191,191,191; --wix-color-29: 128,128,128; --wix-color-30: 64,64,64; --wix-color-31: 12,176,196; --wix-color-32: 208,208,208; --wix-color-33: 243,243,243; --wix-color-34: 115,115,115; --wix-color-35: 0,0,0; --wix-color-36: 255,255,255; --wix-color-37: 64,64,64; --wix-color-38: 12,176,196; --wix-color-39: 12,176,196; --wix-color-40: 255,255,255; --wix-color-41: 255,255,255; --wix-color-42: 12,176,196; --wix-color-43: 12,176,196; --wix-color-44: 128,128,128; --wix-color-45: 128,128,128; --wix-color-46: 255,255,255; --wix-color-47: 255,255,255; --wix-color-48: 12,176,196; --wix-color-49: 12,176,196; --wix-color-50: 12,176,196; --wix-color-51: 12,176,196; --wix-color-52: 255,255,255; --wix-color-53: 255,255,255; --wix-color-54: 128,128,128; --wix-color-55: 128,128,128; --wix-font-Title: normal normal normal 22px/1.41em roboto-bold,roboto,sans-serif; --wix-font-Title-style: normal; --wix-font-Title-variant: normal; --wix-font-Title-weight: normal; --wix-font-Title-size: 22px; --wix-font-Title-line-height: 1.41em; --wix-font-Title-family: roboto-bold,roboto,sans-serif; --wix-font-Title-text-decoration: none; --wix-font-Menu: normal normal normal 14px/1.79em helvetica-w01-roman,sans-serif; --wix-font-Menu-style: normal; --wix-font-Menu-variant: normal; --wix-font-Menu-weight: normal; --wix-font-Menu-size: 14px; --wix-font-Menu-line-height: 1.79em; --wix-font-Menu-family: helvetica-w01-roman,sans-serif; --wix-font-Menu-text-decoration: none; --wix-font-Page-title: normal normal normal 46px/1.2em montserrat,sans-serif; --wix-font-Page-title-style: normal; --wix-font-Page-title-variant: normal; --wix-font-Page-title-weight: normal; --wix-font-Page-title-size: 46px; --wix-font-Page-title-line-height: 1.2em; --wix-font-Page-title-family: montserrat,sans-serif; --wix-font-Page-title-text-decoration: none; --wix-font-Heading-XL: normal normal normal 88px/1.2em roboto-bold,roboto,sans-serif; --wix-font-Heading-XL-style: normal; --wix-font-Heading-XL-variant: normal; --wix-font-Heading-XL-weight: normal; --wix-font-Heading-XL-size: 88px; --wix-font-Heading-XL-line-height: 1.2em; --wix-font-Heading-XL-family: roboto-bold,roboto,sans-serif; --wix-font-Heading-XL-text-decoration: none; --wix-font-Heading-L: normal normal bold 72px/1.1em syne,sans-serif; --wix-font-Heading-L-style: normal; --wix-font-Heading-L-variant: normal; --wix-font-Heading-L-weight: bold; --wix-font-Heading-L-size: 72px; --wix-font-Heading-L-line-height: 1.1em; --wix-font-Heading-L-family: syne,sans-serif; --wix-font-Heading-L-text-decoration: none; --wix-font-Heading-M: normal normal normal 50px/1.34em roboto-bold,roboto,sans-serif; --wix-font-Heading-M-style: normal; --wix-font-Heading-M-variant: normal; --wix-font-Heading-M-weight: normal; --wix-font-Heading-M-size: 50px; --wix-font-Heading-M-line-height: 1.34em; --wix-font-Heading-M-family: roboto-bold,roboto,sans-serif; --wix-font-Heading-M-text-decoration: none; --wix-font-Heading-S: normal normal normal 40px/1.35em roboto-bold,roboto,sans-serif; --wix-font-Heading-S-style: normal; --wix-font-Heading-S-variant: normal; --wix-font-Heading-S-weight: normal; --wix-font-Heading-S-size: 40px; --wix-font-Heading-S-line-height: 1.35em; --wix-font-Heading-S-family: roboto-bold,roboto,sans-serif; --wix-font-Heading-S-text-decoration: none; --wix-font-Body-L: normal normal normal 25px/1.67em montserrat,sans-serif; --wix-font-Body-L-style: normal; --wix-font-Body-L-variant: normal; --wix-font-Body-L-weight: normal; --wix-font-Body-L-size: 25px; --wix-font-Body-L-line-height: 1.67em; --wix-font-Body-L-family: montserrat,sans-serif; --wix-font-Body-L-text-decoration: none; --wix-font-Body-M: normal normal normal 16px/1.8em montserrat,sans-serif; --wix-font-Body-M-style: normal; --wix-font-Body-M-variant: normal; --wix-font-Body-M-weight: normal; --wix-font-Body-M-size: 16px; --wix-font-Body-M-line-height: 1.8em; --wix-font-Body-M-family: montserrat,sans-serif; --wix-font-Body-M-text-decoration: none; --wix-font-Body-S: normal normal normal 14px/1.88em montserrat,sans-serif; --wix-font-Body-S-style: normal; --wix-font-Body-S-variant: normal; --wix-font-Body-S-weight: normal; --wix-font-Body-S-size: 14px; --wix-font-Body-S-line-height: 1.88em; --wix-font-Body-S-family: montserrat,sans-serif; --wix-font-Body-S-text-decoration: none; --wix-font-Body-XS: normal normal normal 14px/1.79em helvetica-w01-roman,sans-serif; --wix-font-Body-XS-style: normal; --wix-font-Body-XS-variant: normal; --wix-font-Body-XS-weight: normal; --wix-font-Body-XS-size: 14px; --wix-font-Body-XS-line-height: 1.79em; --wix-font-Body-XS-family: helvetica-w01-roman,sans-serif; --wix-font-Body-XS-text-decoration: none; --wix-font-LIGHT: normal normal normal 12px/1.4em HelveticaNeueW01-45Ligh; --wix-font-LIGHT-style: normal; --wix-font-LIGHT-variant: normal; --wix-font-LIGHT-weight: normal; --wix-font-LIGHT-size: 12px; --wix-font-LIGHT-line-height: 1.4em; --wix-font-LIGHT-family: HelveticaNeueW01-45Ligh; --wix-font-LIGHT-text-decoration: none; --wix-font-MEDIUM: normal normal normal 12px/1.4em HelveticaNeueW01-55Roma; --wix-font-MEDIUM-style: normal; --wix-font-MEDIUM-variant: normal; --wix-font-MEDIUM-weight: normal; --wix-font-MEDIUM-size: 12px; --wix-font-MEDIUM-line-height: 1.4em; --wix-font-MEDIUM-family: HelveticaNeueW01-55Roma; --wix-font-MEDIUM-text-decoration: none; --wix-font-STRONG: normal normal normal 12px/1.4em HelveticaNeueW01-65Medi; --wix-font-STRONG-style: normal; --wix-font-STRONG-variant: normal; --wix-font-STRONG-weight: normal; --wix-font-STRONG-size: 12px; --wix-font-STRONG-line-height: 1.4em; --wix-font-STRONG-family: HelveticaNeueW01-65Medi; --wix-font-STRONG-text-decoration: none; --wix-direction: ltr; --paddingsTopBottom: 0; --paddingsLeftRight: 0; --headerOneTextFont: normal normal normal 16px/1.4em montserrat; --headerOneTextFont-style: normal; --headerOneTextFont-variant: normal; --headerOneTextFont-weight: normal; --headerOneTextFont-size: 16px; --headerOneTextFont-line-height: 1.4em; --headerOneTextFont-family: montserrat; --headerOneTextFont-text-decoration: none; } .sd6mJz5{cursor:pointer;display:block;padding-top:10px} .sO0EeU2{overflow:hidden} .skxtrJG{text-align:center;border-style:solid;overflow:hidden} .SISpo{margin-inline-start:0!important} .vkkMO{margin-inline-start:40px!important} .AMjGo{margin-inline-start:80px!important} .eXJJ4{margin-inline-start:120px!important} .ik-0p{margin-inline-start:160px!important} .HuCPZ{margin-inline-start:200px!important} .tBG3t{margin-inline-start:240px!important} .BS4JL{margin-left:0;margin-right:auto;z-index:1} .BS4JL:not(._0B1pq){float:left;margin-right:40px}@supports not (contain:inline-size){@media only screen and (max-width:480px){ .BS4JL:not(._0B1pq){float:none;margin-right:auto}}}@container (width *{text-align:left} ._6V-OU, ._6V-OU>*{text-align:center} .HrJC2, .HrJC2>*{text-align:right} .M4Ji4, .M4Ji4>*{text-align:initial} ._7wrCx{text-align:justify!important;white-space:pre-wrap!important} .JN5E8{direction:rtl} .R3MdH{direction:ltr} .GaC3v, .Hquzw, .glob_fontElementMap{font-family:var(--ricos-font-family,unset)} .MLrK-{max-width:100%} .Hquzw{align-content:start;box-sizing:border-box;display:grid;grid-template-columns:minmax(0,1fr);height:100%;position:relative;-webkit-font-smoothing:antialiased;-moz-osx-font-smoothing:grayscale;padding-block-end:var(--ricos-custom-container-padding-block-end,0);padding-block-start:var(--ricos-custom-container-padding-block-start,0)} .Hquzw:has([data-layout-banner]){padding-block-start:0} .Hquzw *{-webkit-tap-highlight-color:rgba(0,0,0,0)} .Hquzw ._9bS1K{box-sizing:border-box;-moz-tab-size:40px;-o-tab-size:40px;tab-size:40px} .Hquzw ._9bS1K *, .Hquzw ._9bS1K :after, .Hquzw ._9bS1K :before{box-sizing:inherit} .Hquzw ._9bS1K input{box-sizing:border-box} .Hquzw.xHzoO{padding-top:50px} ._9bS1K{background-color:var(--ricos-bg-color-container,unset);color:var(--ricos-text-color,#212121);container-type:inline-size;font-size:16px;height:100%;line-height:1.5;overflow-wrap:break-word;width:100%;word-wrap:break-word;white-space:pre-wrap;white-space:break-spaces} ._9bS1K:after{clear:both;content:"";display:table;line-height:0}@supports not (contain:inline-size){@media only screen and (max-width:480px){ ._9bS1K{font-size:14px}}}@container (width span>a, .dSoN4>span>span{background-color:var(--ricos-custom-p-background-color,unset)} .dSoN4:empty{height:24px} .-buxx{display:block} .VnJFi, .glob_fontElementMap{font-family:var(--ricos-font-family,unset)} .flj0N, .wNURH{color:var(--ricos-custom-p-color,unset);font-family:var(--ricos-custom-p-font-family,unset);font-size:var(--ricos-custom-p-font-size,unset);font-style:var(--ricos-custom-p-font-style,unset);font-weight:var(--ricos-custom-p-font-weight,unset);letter-spacing:var(--ricos-custom-p-letter-spacing,unset);line-height:var(--ricos-custom-p-line-height,unset);list-style-position:outside;margin:0;min-height:var(--ricos-custom-p-min-height,unset);padding:0;-webkit-text-decoration:var(--ricos-custom-p-text-decoration,unset);text-decoration:var(--ricos-custom-p-text-decoration,unset)} .flj0N>*, .wNURH>*{background-color:var(--ricos-custom-p-background-color,unset)} .flj0N>.-Z5zC, .wNURH>.-Z5zC{list-style-type:inherit;margin-inline-start:1.5em;padding-inline-start:.5em} .flj0N>.-Z5zC[data-heading-level=headerOne], .wNURH>.-Z5zC[data-heading-level=headerOne]{font-family:var(--ricos-custom-h1-font-family,unset);font-size:var(--ricos-custom-h1-font-size,40px);font-style:var(--ricos-custom-h1-font-style,unset);font-weight:var(--ricos-custom-h1-font-weight,unset);letter-spacing:var(--ricos-custom-h1-letter-spacing,unset);line-height:var(--ricos-custom-h1-line-height,42px);min-height:var(--ricos-custom-h1-min-height,42px);-webkit-text-decoration:var(--ricos-custom-h1-text-decoration,unset);text-decoration:var(--ricos-custom-h1-text-decoration,unset)} .flj0N>.-Z5zC[data-heading-level=headerTwo], .wNURH>.-Z5zC[data-heading-level=headerTwo]{font-family:var(--ricos-custom-h2-font-family,unset);font-size:var(--ricos-custom-h2-font-size,28px);font-style:var(--ricos-custom-h2-font-style,unset);font-weight:var(--ricos-custom-h2-font-weight,unset);letter-spacing:var(--ricos-custom-h2-letter-spacing,unset);line-height:var(--ricos-custom-h2-line-height,36px);min-height:var(--ricos-custom-h2-min-height,36px);-webkit-text-decoration:var(--ricos-custom-h2-text-decoration,unset);text-decoration:var(--ricos-custom-h2-text-decoration,unset)} .flj0N>.-Z5zC[data-heading-level=headerThree], .wNURH>.-Z5zC[data-heading-level=headerThree]{font-family:var(--ricos-custom-h3-font-family,unset);font-size:var(--ricos-custom-h3-font-size,24px);font-style:var(--ricos-custom-h3-font-style,unset);font-weight:var(--ricos-custom-h3-font-weight,unset);letter-spacing:var(--ricos-custom-h3-letter-spacing,unset);line-height:var(--ricos-custom-h3-line-height,30px);min-height:var(--ricos-custom-h3-min-height,30px);-webkit-text-decoration:var(--ricos-custom-h3-text-decoration,unset);text-decoration:var(--ricos-custom-h3-text-decoration,unset)} .flj0N>.-Z5zC[data-heading-level=headerFour], .wNURH>.-Z5zC[data-heading-level=headerFour]{font-family:var(--ricos-custom-h4-font-family,unset);font-size:var(--ricos-custom-h4-font-size,20px);font-style:var(--ricos-custom-h4-font-style,unset);font-weight:var(--ricos-custom-h4-font-weight,unset);letter-spacing:var(--ricos-custom-h4-letter-spacing,unset);line-height:var(--ricos-custom-h4-line-height,1.5);min-height:var(--ricos-custom-h4-min-height,unset);-webkit-text-decoration:var(--ricos-custom-h4-text-decoration,unset);text-decoration:var(--ricos-custom-h4-text-decoration,unset)} .flj0N>.-Z5zC[data-heading-level=headerFive], .wNURH>.-Z5zC[data-heading-level=headerFive]{font-family:var(--ricos-custom-h5-font-family,unset);font-size:var(--ricos-custom-h5-font-size,18px);font-style:var(--ricos-custom-h5-font-style,unset);font-weight:var(--ricos-custom-h5-font-weight,unset);letter-spacing:var(--ricos-custom-h5-letter-spacing,unset);line-height:var(--ricos-custom-h5-line-height,1.5);min-height:var(--ricos-custom-h5-min-height,unset);-webkit-text-decoration:var(--ricos-custom-h5-text-decoration,unset);text-decoration:var(--ricos-custom-h5-text-decoration,unset)} .flj0N>.-Z5zC[data-heading-level=headerSix], .wNURH>.-Z5zC[data-heading-level=headerSix]{font-family:var(--ricos-custom-h6-font-family,unset);font-size:var(--ricos-custom-h6-font-size,16px);font-style:var(--ricos-custom-h6-font-style,unset);font-weight:var(--ricos-custom-h6-font-weight,unset);letter-spacing:var(--ricos-custom-h6-letter-spacing,unset);line-height:var(--ricos-custom-h6-line-height,1.5);min-height:var(--ricos-custom-h6-min-height,unset);-webkit-text-decoration:var(--ricos-custom-h6-text-decoration,unset);text-decoration:var(--ricos-custom-h6-text-decoration,unset)} [data-list-style-position=inside].-Z5zC{list-style-position:inside;padding-inline-start:0} [data-list-style-position=inside].-Z5zC>:first-child, [data-list-style-position=inside].-Z5zC>:first-child>:first-child{display:inline} .wNURH>[data-list-style-position=inside].-Z5zC h2>span, .wNURH>[data-list-style-position=inside].-Z5zC h3>span, .wNURH>[data-list-style-position=inside].-Z5zC h4>span, .wNURH>[data-list-style-position=inside].-Z5zC h5>span, .wNURH>[data-list-style-position=inside].-Z5zC h6>span, .wNURH>[data-list-style-position=inside].-Z5zC>h1>span, .wNURH>[data-list-style-position=inside].-Z5zC>p>span>:first-child{margin-inline-start:.5em}ol .-Z5zC{position:relative}ol .-Z5zC>div>:not(ul)>span{margin-inline-start:.35em} .OvgnE{background:var(--ricos-internal-layout-backdrop-gradient,var(--ricos-internal-layout-backdrop-color,var(--ricos-custom-layout-backdrop-color)));clear:both;padding-bottom:var(--ricos-internal-layout-backdrop-padding-bottom,0);padding-top:var(--ricos-internal-layout-backdrop-padding-top,0);position:relative} .OvgnE:before{background-image:var(--ricos-internal-layout-backdrop-image-src);background-position:var(--ricos-internal-layout-backdrop-image-position);background-repeat:no-repeat;background-size:var(--ricos-internal-layout-backdrop-image-scaling);bottom:0;content:"";left:0;opacity:var(--ricos-internal-layout-backdrop-image-opacity);pointer-events:none;position:absolute;right:0;top:0;z-index:0} .sJllg{--ricos-internal-layout-display:grid;--ricos-internal-layout-horizontal-padding:0;display:var(--ricos-internal-layout-display,grid);flex-wrap:wrap;gap:var(--ricos-internal-layout-gap,20px);grid-template-columns:var(--ricos-internal-layout-grid-template,var(--ricos-internal-layout-column-template));justify-content:var(--ricos-internal-layout-justify-content,auto);margin:0 auto;position:relative;width:min(100%,var(--ricos-internal-layout-width,initial))} .sJllg.FfOa5 ._7GM66, .sJllg.so7PZ{background:var(--ricos-internal-layout-background-gradient,var(--ricos-internal-layout-background-color,var(--ricos-custom-layout-background-color)));border:var(--ricos-internal-layout-border-width,0) solid var(--ricos-internal-layout-border-color);border-radius:var(--ricos-internal-layout-border-radius,0)} .sJllg.FfOa5 ._7GM66:before, .sJllg.so7PZ:before{background-image:var(--ricos-internal-layout-background-image-src);background-position:var(--ricos-internal-layout-background-image-position);background-repeat:no-repeat;background-size:var(--ricos-internal-layout-background-image-scaling);border-radius:calc(var(--ricos-internal-layout-border-radius, 0) - var(--ricos-internal-layout-border-width, 0));bottom:0;content:"";left:0;opacity:var(--ricos-internal-layout-background-image-opacity);pointer-events:none;position:absolute;right:0;top:0;z-index:0}@supports not (contain:inline-size){@media only screen and (max-width:480px){ .sJllg{gap:min(20px,var(--ricos-internal-layout-gap,20px))}}}@container (width *{z-index:1} .NeRCw, .glob_fontElementMap{font-family:var(--ricos-font-family,unset)} .U65xw{display:flex;font-family:var(--ricos-custom-p-font-family,unset)} .STqi9{border-inline-start-style:solid;border-inline-start-width:var(--ricos-custom-quote-border-width,3px);border-left-color:var(--ricos-custom-quote-border-color,var(--ricos-action-color,#116dff));border-right-color:var(--ricos-custom-quote-border-color,var(--ricos-action-color,#116dff));color:var(--ricos-custom-quote-color,unset);font-family:var(--ricos-custom-quote-font-family,unset);font-size:18px;font-size:var(--ricos-custom-quote-font-size,18px);font-style:normal;font-style:var(--ricos-custom-quote-font-style,normal);font-weight:var(--ricos-custom-quote-font-weight,unset);letter-spacing:var(--ricos-custom-quote-letter-spacing,unset);line-height:26px;line-height:var(--ricos-custom-quote-line-height,26px);margin-block:15px;margin-inline-end:var(--ricos-custom-quote-margin-inline-end,18px);margin-inline-start:var(--ricos-custom-quote-margin-inline-start,18px);max-width:100%;min-height:var(--ricos-custom-quote-min-height,unset);padding-bottom:var(--ricos-custom-quote-padding-bottom,6px);padding-top:var(--ricos-custom-quote-padding-top,6px);padding-inline-start:var(--ricos-custom-quote-padding-inline-start,18px);-webkit-print-color-adjust:exact;print-color-adjust:exact;-webkit-text-decoration:var(--ricos-custom-quote-text-decoration,unset);text-decoration:var(--ricos-custom-quote-text-decoration,unset)}@supports not (contain:inline-size){@media only screen and (max-width:480px){ .STqi9{margin-block:15px;margin-inline-end:var(--ricos-custom-quote-margin-inline-end,16px);margin-inline-start:var(--ricos-custom-quote-margin-inline-start,16px)}}}@container (width *>span, .X3hFm>span span{background-color:var(--ricos-custom-h1-background-color,unset)} .X3hFm a{font-size:inherit} ._1rWEn{color:var(--ricos-custom-h2-color,var(--ricos-text-color,#212121));font-family:var(--ricos-custom-h2-font-family,unset);font-size:var(--ricos-custom-h2-font-size,28px);font-style:var(--ricos-custom-h2-font-style,unset);font-weight:var(--ricos-custom-h2-font-weight,unset);letter-spacing:var(--ricos-custom-h2-letter-spacing,unset);line-height:var(--ricos-custom-h2-line-height,36px);min-height:var(--ricos-custom-h2-min-height,36px);-webkit-text-decoration:var(--ricos-custom-h2-text-decoration,unset);text-decoration:var(--ricos-custom-h2-text-decoration,unset)} ._1rWEn>*>span, ._1rWEn>span span{background-color:var(--ricos-custom-h2-background-color,unset)} ._1rWEn a{font-size:inherit} .VCTXo{color:var(--ricos-custom-h3-color,var(--ricos-text-color,#212121));font-family:var(--ricos-custom-h3-font-family,unset);font-size:var(--ricos-custom-h3-font-size,24px);font-style:var(--ricos-custom-h3-font-style,unset);font-weight:var(--ricos-custom-h3-font-weight,unset);letter-spacing:var(--ricos-custom-h3-letter-spacing,unset);line-height:var(--ricos-custom-h3-line-height,30px);min-height:var(--ricos-custom-h3-min-height,30px);-webkit-text-decoration:var(--ricos-custom-h3-text-decoration,unset);text-decoration:var(--ricos-custom-h3-text-decoration,unset)} .VCTXo>*>span, .VCTXo>span span{background-color:var(--ricos-custom-h3-background-color,unset)} .VCTXo a{font-size:inherit} .bu9P1{color:var(--ricos-custom-h4-color,var(--ricos-text-color,#212121));font-family:var(--ricos-custom-h4-font-family,unset);font-size:var(--ricos-custom-h4-font-size,20px);font-style:var(--ricos-custom-h4-font-style,unset);font-weight:var(--ricos-custom-h4-font-weight,unset);letter-spacing:var(--ricos-custom-h4-letter-spacing,unset);line-height:var(--ricos-custom-h4-line-height,1.5);min-height:var(--ricos-custom-h4-min-height,unset);-webkit-text-decoration:var(--ricos-custom-h4-text-decoration,unset);text-decoration:var(--ricos-custom-h4-text-decoration,unset)} .bu9P1>*>span, .bu9P1>span span{background-color:var(--ricos-custom-h4-background-color,unset)} .bu9P1 a{font-size:inherit} ._45HG3{color:var(--ricos-custom-h5-color,var(--ricos-text-color,#212121));font-family:var(--ricos-custom-h5-font-family,unset);font-size:var(--ricos-custom-h5-font-size,18px);font-style:var(--ricos-custom-h5-font-style,unset);font-weight:var(--ricos-custom-h5-font-weight,unset);letter-spacing:var(--ricos-custom-h5-letter-spacing,unset);line-height:var(--ricos-custom-h5-line-height,1.5);min-height:var(--ricos-custom-h5-min-height,unset);-webkit-text-decoration:var(--ricos-custom-h5-text-decoration,unset);text-decoration:var(--ricos-custom-h5-text-decoration,unset)} ._45HG3>*>span, ._45HG3>span span{background-color:var(--ricos-custom-h5-background-color,unset)} ._45HG3 a{font-size:inherit} ._34cRM{color:var(--ricos-custom-h6-color,var(--ricos-text-color,#212121));font-family:var(--ricos-custom-h6-font-family,unset);font-size:var(--ricos-custom-h6-font-size,16px);font-style:var(--ricos-custom-h6-font-style,unset);font-weight:var(--ricos-custom-h6-font-weight,unset);letter-spacing:var(--ricos-custom-h6-letter-spacing,unset);line-height:var(--ricos-custom-h6-line-height,1.5);min-height:var(--ricos-custom-h6-min-height,unset);-webkit-text-decoration:var(--ricos-custom-h6-text-decoration,unset);text-decoration:var(--ricos-custom-h6-text-decoration,unset)} ._34cRM>*>span, ._34cRM>span span{background-color:var(--ricos-custom-h6-background-color,unset)} ._34cRM a{font-size:inherit} .K8fmE{display:block} .GBZwB, .glob_fontElementMap{font-family:var(--ricos-font-family,unset)} .yLISN{color:var(--ricos-custom-hashtag-color,var(--ricos-action-color,var(--ricos-custom-p-color,#116dff)));font-family:var(--ricos-custom-hashtag-font-family,unset);font-size:var(--ricos-custom-hashtag-font-size,unset);font-style:var(--ricos-custom-hashtag-font-style,unset);font-weight:var(--ricos-custom-hashtag-font-weight,unset);letter-spacing:var(--ricos-custom-hashtag-letter-spacing,unset);line-height:var(--ricos-custom-hashtag-line-height,unset);min-height:var(--ricos-custom-hashtag-min-height,unset);-webkit-text-decoration:var(--ricos-custom-hashtag-text-decoration,none);text-decoration:var(--ricos-custom-hashtag-text-decoration,none)} .yLISN:hover{text-decoration:underline} ._8lXj2, ._8lXj2:visited{background:var(--ricos-custom-mention-background-color,transparent)!important;border-radius:2px;color:var(--ricos-custom-mention-color,var(--ricos-action-color,#116dff));display:inline-block;padding-left:2px;padding-right:2px;text-decoration:none} .ZMc2a, .ZMc2a:visited{padding-left:4px;padding-right:4px} ._8lXj2:focus, ._8lXj2:hover{outline:0;text-decoration:underline} ._8lXj2:active, ._8lXj2:focus, ._8lXj2:hover{color:var(--ricos-custom-mention-color,var(--ricos-action-color,#116dff))} .XXGd0{cursor:default} ._7ijVQ{cursor:pointer} .sLOzPjG.oOwuCrc--madefor{--wbu-font-stack:var(--wix-font-stack);--wbu-font-weight-regular:var(--wix-font-weight-regular);--wbu-font-weight-medium:var(--wix-font-weight-medium);--wbu-font-weight-bold:var(--wix-font-weight-bold)} @charset "UTF-8"; .QuPyW, .glob_fontElementMap{font-family:var(--ricos-font-family,unset)} .qUnge{filter:blur(.25em)} .z-Jqy{cursor:pointer;filter:blur(.18em)} .yOXK1>*{pointer-events:none} .vnbn3>*{filter:blur(30px)} .fWo1N>*{filter:blur(40px)} .-JGms>*{filter:blur(50px)} .VQoSX div[class^=gallery-item-wrapper], .VQoSX div[class^=thumbnailItem]{filter:blur(30px)} .VQoSX>*{pointer-events:none} .xlpa-{background-color:rgba(0,0,0,.3)} .ST6d2, .xlpa-{display:block;height:100%;left:0;position:absolute;top:0;width:100%} .ST6d2{background:linear-gradient(0deg,transparent 50%,#202020)} .-EBFx{background-color:#fff;border:none;color:var(--ricos-settings-text-color,#000);filter:none;font-size:16px;height:40px;max-width:260px;padding:8px 16px;width:-moz-max-content;width:max-content} .sSgSO .-EBFx{font-size:14px} .-EBFx input{border:none;font-size:inherit;max-width:228px;padding:0;text-align:center} .D6hIV:hover{cursor:pointer;opacity:.7} .VBOUj{overflow:hidden;position:relative;width:100%;z-index:7} .t-sff{background:none;border:none;color:#fff;display:flex;font-family:var(--ricos-settings-text-font-family,Madefor,"Helvetica Neue",Helvetica,Arial,メイリオ,meiryo,"ヒラギノ角ゴ pro w3","hiragino kaku gothic pro",sans-serif);font-size:16px;font-weight:400;line-height:24px;margin-bottom:28px;margin-left:5%;margin-top:12px;pointer-events:auto!important;resize:none;text-align:center;width:90%} .sSgSO .t-sff{font-size:14px;margin-bottom:20px} ._4CMWm{margin:0;top:50%;transform:translate(-50%,-50%)} ._4CMWm, .z7FUl{color:#fff;left:50%;position:absolute;text-align:center;z-index:1} .z7FUl{margin-top:24px;transform:translate(-50%)}@media print{ .VQoSX div[class^=gallery-item-wrapper], .VQoSX div[class^=thumbnailItem], ._7n-ap, .qUnge, .z-Jqy, [style*=blur],span._7n-ap,span[style*=blur]{filter:none!important} .ST6d2, ._4CMWm, .xlpa-, .z7FUl{display:none!important}} .-DU9A{background:var(--ricos-internal-button-background,var(--ricos-custom-button-background-color,var(--ricos-action-color,#116dff)));border:var(--ricos-internal-button-border-width,var(--ricos-custom-button-border-width,0)) solid var(--ricos-internal-button-border-color,var(--ricos-custom-button-border-color,var(--ricos-text-on-action-color,var(--ricos-background-color,#fff))));border-radius:var(--ricos-internal-button-border-radius,var(--ricos-custom-button-border-radius));box-sizing:border-box;color:var(--ricos-internal-button-color,var(--ricos-custom-button-color,var(--ricos-text-on-action-color,var(--ricos-background-color,#fff))));cursor:pointer;display:block;font-size:var(--ricos-internal-button-font-size,14px);padding:var(--ricos-internal-button-padding,12px);position:relative;text-decoration:none;width:min(100%,var(--ricos-internal-button-custom-width),auto)} .-DU9A:hover, .forced-hover .-DU9A{background:var(--ricos-internal-button-background-hover,var(--ricos-custom-button-background-color-hover,var(--ricos-action-color,#116dff)));border:var(--ricos-internal-button-border-width,var(--ricos-custom-button-border-width,0)) solid var(--ricos-internal-button-border-color-hover,var(--ricos-custom-button-border-color-hover,var(--ricos-text-on-action-color,var(--ricos-background-color,#fff))));color:var(--ricos-internal-button-color-hover,var(--ricos-custom-button-color-hover,var(--ricos-text-on-action-color,var(--ricos-background-color,#fff))))} .JpuEb{font-family:var(--ricos-custom-p-font-family,unset);line-height:21px;min-width:16px;overflow:hidden;text-align:center;text-overflow:ellipsis;white-space:nowrap} .bCL2W{width:auto} .comp-l4zr92q41 .sd6mJz5{color:;font:undefined;text-decoration: } .comp-l4zr92q41 .sO0EeU2{height:NaNpx} .comp-l4zr92q41 .skxtrJG{background-color:;padding:0px 0px;border-color:;border-width:NaNpx;border-radius:NaNpx} .comp-l4zr92q41 .skxtrJG.o_qHEgZ--isMobile{padding:min(0px,20px) min(0px,20px)} Emeryville, California, November 3, 2025 – Estrella Immunopharma, Inc. (NASDAQ: ESLA) (“Estrella” or the “Company”), a clinical stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS® T-cell therapies to treat cancer and autoimmune diseases, today announced the successful completion of the second dose cohort in Phase I portion of its STARLIGHT-1 Phase I/II clinical trial of EB103, a CD19-redirected ARTEMIS® T-cell therapy to treat patients with Advanced B-Cell Non-Hodgkin’s Lymphomas (NHL). Key Findings: The study has achieved a 100% complete response (CR) rate at Month 1 in all evaluable patients treated in the second dose cohort. All patients treated are considered high-risk group who are not suitable to receive commercial CD19 products, including one with Central Nervous System (CNS) lymphoma. No treatment-related serious adverse events (SAEs) were reported during this study phase. “Completing the second dose cohort with a 100% CR rate marks a significant milestone in our EB103 clinical program,” said Cheng Liu, PhD, Chief Executive Officer of Estrella. “We’re especially encouraged by the favorable safety profile observed in this high-risk group, including a CNS-involved patient, which demonstrates the potential of EB103 as a safe and effective treatment for a broader population of cancer patients who have limited options. We look forward to taking EB103 into the dose expansion phase of STARLIGHT-1.” The second dose cohort included patients with relapsed/refractory B-cell NHL who have failed multiple prior lines of therapy. Following the completion of this dose cohort, a Data and Safety Monitoring Board (DSMB) will review the cumulative study data to evaluate the safety and efficacy of EB103, and to determine the Recommended Phase II Dose (RP2D) for the expansion phase. The DSMB is an independent group of experts that assesses the study's progress and makes recommendations to the trial's sponsor. The Phase I/II clinical trial for EB103 is an open-label, dose escalation, multi-center, Phase I/II clinical trial to assess the safety of EB103 autologous T-cell therapy and to determine RP2D in adult subjects (≥ 18 years of age) who have relapsed/refractory (R/R) B-cell NHL. The study includes a dose escalation phase followed by an expansion phase. Further details of the trial can be found at www.clinicaltrials.gov under NCT identifier: NCT06343311. About EB103 EB103, a T-cell therapy, also referred to as Estrella’s “CD19-Redirected ARTEMIS® T-Cell Therapy,” utilizes ARTEMIS® technology licensed from Eureka Therapeutics, Inc. (“Eureka”), Estrella’s parent company. Unlike a traditional CAR-T cell, the unique design of an ARTEMIS® T-Cell, like EB103 T-cell, allows it to be activated and regulated upon engagement with cancer targets that use a cellular mechanism more closely resembling the one from an endogenous T-cell receptor. Once infused, EB103 T cells bind to and destroy CD19-positive cancer cells. About Estrella Immunopharma Estrella is a clinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS® T-cell therapies to treat cancers and autoimmune diseases. Estrella’s mission is to harness the evolutionary power of the human immune system to transform the lives of patients fighting cancer and other diseases. To accomplish this mission, Estrella’s lead product candidate, EB103, utilizes Eureka’s ARTEMIS® technology to target CD19, a protein expressed on the surface of almost all B-cell leukemias and lymphomas. Estrella is also developing EB104, which also utilizes Eureka’s ARTEMIS® technology to target not only CD19, but also CD22, another protein expressed on the surface of most B-cell malignancies. For more information about Estrella, please visit www.estrellabio.com . Forward Looking Statements This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements, including but not limited to those regarding the potential benefits, safety, and therapeutic advantages of EB103 and ARTEMIS® T-cell therapy, the anticipated progress and milestones of the STARLIGHT-1 Phase I/II clinical trial, and the future development plans for EB103, are based on our management’s current expectations, estimates, forecasts, and projections about the industry and markets in which we operate and our management’s current beliefs and assumptions. These statements may be identified by the use of forward-looking expressions, including, but not limited to, “expect,” “anticipate,” “intend,” “plan,” “believe,” “estimate,” “potential,” “predict,” “project,” “should,” “would” and similar expressions and the negatives of those terms. These statements relate to future events or our financial performance and involve known and unknown risks, uncertainties, and other factors that could cause actual results, levels of activity, performance, or achievements to differ materially from those expressed or implied by these forward-looking statements. Factors that may cause actual results to differ materially from current expectations include, among other things, those listed under “Risk Factors” and elsewhere in our filings with the Securities and Exchange Commission. The forward-looking statements in this press release represent our views as of the date of this press release. We anticipate that subsequent events and developments will cause our views to change. However, while we may elect to update these forward-looking statements at some point in the future, we have no current intention of doing so except to the extent required by applicable law. You should, therefore, not rely on these forward-looking statements as representing our views as of any date subsequent to the date of this press release.

The release as fetched from its publisher. estrellabio.com ↗